Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00117962

Public ClinicalTrials.gov record NCT00117962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 2, 2026, 2:44 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase II Study of Radiation Therapy, Pemetrexed and Carboplatin With or Without Cetuximab in Stage III Non-Small Cell Lung Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Pemetrexed disodium may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Cetuximab may also make tumor cells more sensitive to radiation therapy. Giving pemetrexed disodium, carboplatin, and radiation therapy together with cetuximab may kill more tumor cells. PURPOSE: This randomized phase II trial is studying how well giving pemetrexed disodium and carboplatin together with radiation therapy with or without cetuximab works in treating patients with stage III non-small cell lung cancer that cannot be removed by surgery.

Study identification

NCT ID
NCT00117962
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
109 participants

Conditions and interventions

Conditions

Interventions

Biological · Drug · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2005 (Type not available)
Primary completion
Mar 2009 (Actual)
Completion
Sep 2012 (Actual)
Last update posted
Oct 7, 2016

2005 – 2012

United States locations

U.S. sites
71
U.S. states
26
U.S. cities
59
Facility City State ZIP Site status
Arroyo Grande Community Hospital Arroyo Grande California 93420 —
Eden Medical Center Castro Valley California 94546 —
Saint Rose Hospital Hayward California 94545 —
Rebecca and John Moores UCSD Cancer Center La Jolla California 92093-0658 —
Highland General Hospital Oakland California 94602 —
Alta Bates Summit Medical Center - Summit Campus Oakland California 94609 —
CCOP - Bay Area Tumor Institute Oakland California 94609 —
Valley Care Medical Center Pleasanton California 94588 —
Doctors Medical Center - San Pablo Campus San Pablo California 94806 —
Bendheim Cancer Center at Greenwich Hospital Greenwich Connecticut 06830 —
Tunnell Cancer Center at Beebe Medical Center Lewes Delaware 19958 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
Sibley Memorial Hospital Washington D.C. District of Columbia 20016 —
Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando Florida 32803-1273 —
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia 31403-3089 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
Louis A. Weiss Memorial Hospital Chicago Illinois 60640 —
La Grange Memorial Hospital La Grange Illinois 60525 —
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46815 —
Hematology Oncology Associates of the Quad Cities Bettendorf Iowa 52722 —
Iowa Blood and Cancer Care Cedar Rapids Iowa 52402 —
St. Luke's Hospital Cedar Rapids Iowa 52402 —
Mercy Regional Cancer Center at Mercy Medical Center Cedar Rapids Iowa 52403 —
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242-1002 —
Greenebaum Cancer Center at University of Maryland Medical Center Baltimore Maryland 21201 —
Upper Chesapeake Medical Center Bel Air Maryland 21014 —
Union Hospital Cancer Program at Union Hospital Elkton MD Maryland 21921 —
Hudner Oncology Center at Saint Anne's Hospital - Fall River Fall River Massachusetts 02721 —
Saint Luke's Hospital Chesterfield Missouri 63017 —
Missouri Cancer Associates Columbia Missouri 65201 —
Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - Saint Louis St Louis Missouri 63110 —
St. Anthony's Cancer Center St Louis Missouri 63128 —
Missouri Baptist Cancer Center St Louis Missouri 63131 —
Arch Medical Services, Incorporated at Center for Cancer Care and Research St Louis Missouri 63141 —
Saint Francis Cancer Treatment Center at Saint Francis Memorial Health Center Grand Island Nebraska 68803 —
Callahan Cancer Center at Great Plains Regional Medical Center North Platte Nebraska 69103 —
UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha Nebraska 68198-6805 —
University Medical Center of Southern Nevada Las Vegas Nevada 89102 —
CCOP - Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
New Hampshire Oncology - Hematology, PA - Hooksett Hooksett New Hampshire 03106 —
Lakes Region General Hospital Laconia New Hampshire 03246 —
Elliot Regional Cancer Center at Elliot Hospital Manchester New Hampshire 03103 —
St. Joseph's Hospital and Medical Center Paterson New Jersey 07503 —
Cancer Institute of New Jersey at Cooper - Voorhees Voorhees Township New Jersey 08043 —
CCOP - Hematology-Oncology Associates of Central New York East Syracuse New York 13057 —
Charles R. Wood Cancer Center at Glens Falls Hospital Glens Falls New York 12801 —
Mount Sinai Medical Center New York New York 10029 —
SUNY Upstate Medical University Hospital Syracuse New York 13210 —
Veterans Affairs Medical Center - Syracuse Syracuse New York 13210 —
Mission Hospitals - Memorial Campus Asheville North Carolina 28801 —
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
Wayne Memorial Hospital, Incorporated Goldsboro North Carolina 27534 —
Pardee Memorial Hospital Hendersonville North Carolina 28791 —
Kinston Medical Specialists Kinston North Carolina 28501 —
FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center Pinehurst North Carolina 28374 —
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus Ohio 43210-1240 —
Oklahoma University Cancer Institute Oklahoma City Oklahoma 73104 —
Cancer Care Associates - Mercy Campus Oklahoma City Oklahoma 73120 —
Rhode Island Hospital Comprehensive Cancer Center Providence Rhode Island 02903 —
Miriam Hospital Providence Rhode Island 02906 —
Roper St. Francis Cancer Center at Roper Hospital Charleston South Carolina 29401 —
McLeod Regional Medical Center Florence South Carolina 29501 —
Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center Kingsport Tennessee 37662 —
Mountainview Medical Berlin Corners Vermont 05602 —
Fletcher Allen Health Care - University Health Center Campus Burlington Vermont 05401 —
Danville Regional Medical Center Danville Virginia 24541 —
Ravenel Oncology Center at Memorial Hospital of Martinsville and Henry County Martinsville Virginia 24115 —
Southwest Virginia Regional Cancer Center at Wellmonth Health Norton Virginia 24273 —
Virginia Commonwealth University Massey Cancer Center Richmond Virginia 23298-0037 —
St. Mary's Regional Cancer Center at St. Mary's Medical Center Huntington West Virginia 25702 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00117962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 7, 2016 · Synced Nov 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00117962 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →